Landscape Capital Management L.L.C. Takes Position in HCA Healthcare, Inc. $HCA

Landscape Capital Management L.L.C. bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) during the second quarter, HoldingsChannel.com reports. The firm bought 6,186 shares of the company’s stock, valued at approximately $2,412,000.

Several other institutional investors have also recently added to or reduced their stakes in HCA. Sumitomo Life Insurance Co. boosted its position in shares of HCA Healthcare by 1.0% in the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares during the last quarter. MJP Associates Inc. ADV increased its holdings in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC boosted its holdings in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after acquiring an additional 21 shares during the last quarter. Anchyra Partners LLC increased its stake in HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after acquiring an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd lifted its stake in shares of HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after purchasing an additional 22 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have issued reports on HCA. TD Cowen decreased their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Leerink Partners lowered their price target on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Mizuho decreased their target price on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research report on Tuesday, July 28th. KeyCorp reduced their price target on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research report on Monday, July 27th. Finally, Argus dropped their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $462.64.

Read Our Latest Research Report on HCA Healthcare

HCA Healthcare Stock Up 5.6%

Shares of HCA Healthcare stock opened at $429.08 on Friday. The business has a 50-day moving average price of $397.16 and a 200 day moving average price of $444.14. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm has a market cap of $92.90 billion, a P/E ratio of 14.36, a P/E/G ratio of 1.49 and a beta of 1.10.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the firm posted $6.84 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.